Explore how the rise of weight-loss drugs in India may seem like a quick fix but carry serious health risks. We uncover seven ...
Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...
Gallup’s latest health index links the rapid rise of semaglutide and similar injectables to measurable population-level ...
India Today on MSN
Weight loss vs. fat loss: The key difference every diabetic should know
Many diabetics celebrate a drop in the weighing scale without realising that not all weight loss is good news. Experts ...
Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...
Foodsmart, the leading telenutrition and foodcare provider nationwide, is expanding access to its GLP-1 Companion Care program after validating savings of $2,000 per GLP-1 patient annually versus ...
Losing weight is often discussed for health, but fat loss is key for insulin sensitivity. Focusing on reducing fat, ...
This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Bone Loss? Key takeaways: Taking Ozempic® may ...
Americans are jumping for jabs. Surveys show at least one in eight US adults have given GLP-1 drugs like Ozempic and Wegovy a shot, with 6% currently taking them. The miracle meds have been linked to ...
With weight loss drug advertisements infiltrating aspects of everyday life from scrolling on social media to in-person shopping, it’s become quite clear just how mainstream these medications are now.
In the United States, 73.6 percent of adults are overweight or obese, with 41.9 percent classified as obese. Excess weight increases the risk of type 2 diabetes, cardiovascular disease, stroke, ...
Weight loss injections have gained popularity as a quick solution for shedding pounds, but are they safe? We’ll explore the safety, benefits and potential risks associated with weight loss injections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results